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Abstract
Background: Age- and sex-related susceptibility to adverse drug reactions and disease is a key concern in
understanding drug safety and disease progression. We hypothesize that the underlying suite of hepatic genes
expressed at various life cycle stages will impact susceptibility to adverse drug reactions. Understanding the basal
liver gene expression patterns is a necessary first step in addressing this hypothesis and will inform our
assessments of adverse drug reactions as the liver plays a central role in drug metabolism and biotransformation.
Untreated male and female F344 rats were sacrificed at 2, 5, 6, 8, 15, 21, 52, 78, and 104 weeks of age. Liver tissues
were collected for histology and gene expression analysis. Whole-genome rat microarrays were used to query
global expression profiles.
Results: An initial list of differentially expressed genes was selected using criteria based upon p-value (p < 0.05)
and fold-change (+/- 1.5). Three dimensional principal component analyses revealed differences between males
and females beginning at 2 weeks with more divergent profiles beginning at 5 weeks. The greatest sex-differences
were observed between 8 and 52 weeks before converging again at 104 weeks. K-means clustering identified
groups of genes that displayed age-related patterns of expression. Various adult aging-related clusters represented
gene pathways related to xenobiotic metabolism, DNA damage repair, and oxidative stress.
Conclusions: These results suggest an underlying role for genes in specific clusters in potentiating age- and sex-
related differences in susceptibility to adverse health effects. Furthermore, such a comprehensive picture of life
cycle changes in gene expression deepens our understanding and informs the utility of liver gene expression
biomarkers.
Background
The liver’s ability to process exogenous chemicals and
protect itself from injury is influenced by many factors,
including an individual’s age [1], sex [2], ethnicity [3],
genotype [4], and diet [5]. Age- and sex-dependent fac-
tors are decidedly innate and comprise two of the most
important variables in gauging liver function and
responsiveness to chemical insult. Because the liver is
the first and primary line of defense against the poten-
tially toxic effects of oral xenobiotics [6,7], inquiry into
its gene expression profiles to assess potential suscept-
ibilities was performed. Not all potential causes of sus-
ceptibility were examined, only those gene expression
changes associated with sex and age. Some important
gene regulatory events may not be evident at the RNA
level, in the tissue examined (liver), or in the absence of
chemical challenge. Mechanisms of susceptibility may
also be dependent on non-transcriptional events such as
protein expression and modifications, as well as poly-
morphisms in specific genes and proteins, which lie
beyond the scope of the current study. Nonetheless,
capturing baseline gene expression profile measurements
is a necessary first step in characterizing the suite of
genes differentially expressed at various ages.
Age-dependency in susceptibility to drug induced liver
injury (DILI) has been established clinically. For exam-
ple, age has been shown as a predisposing factor for
adverse effects of the antiepileptic drugs carbamazepine
and valproate [8]. In the case of carbamazepine, elderly
patients appear to be at increased risk of developing
blood dyscrasias and liver reactions whereas risk for
adverse liver reactions to valproate is associated with
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reported: for example, acetaminophen seems to exhibit
female-specific susceptibilities in clinical and epidemiol-
ogy studies [9,10]. However, it remains to be seen if
higher rates of female DILI are due to intrinsic (biology)
versus extrinsic (increased use) factors. Whether sus-
ceptibilities to DILI are generally more common in
males versus females have not been as clearly demon-
strated clinically when considering all drugs [11-13].
This suggests that when sex-specific susceptibilities are
present, the sex-specificity varies from drug to drug.
It is well understood that the liver’s drug metabolizing
capacity is a function of its gene expression levels [14].
Furthermore, transcriptome profiling continues to play
an increasing role in estimating toxicity and efficacy of
various drugs in the liver in preclinical and clinical eva-
luations [15,16]. Several prior studies have evaluated
hepatic gene expression differences between young and
old animals or evaluated sex differences on a relatively
limited scale [17-22]. However, a more comprehensive
evaluation of the whole genome during time points
spanning immature, pubertal, early adult and aging
adult animals, in both sexes, would provide greater
interpretive power to assess life cycle liver gene expres-
sion and its impact on drug safety and disease. This
study provides a comprehensive look at liver gene
expression in untreated male and female rats throughout
the entire life cycle in order to assess the basal level
profiles of liver genes that may underlie patterns of sus-
ceptibility due to sex and age.
Results
A comprehensive time-course study, comprising nine
age groups spanning the entire life cycle (between 2
weeks and 2 years of age) of Fischer 344 rats was per-
formed in both male and female animals (Figure 1A).
Terminal body weights were recorded for each animal
(Figure 1B) and the corresponding growth curves are
consistent with historical findings [23]. An original
number of sixteen animals of both sexes was included
in the 104 week group. However, consistent with pre-
vious reports [24], 10 male animals were found to be
moribund or died prior to 104 weeks and were thus
removed from the study. No female animals were
removed early. Pathological examinations were per-
formed on animals at 52, 78 and 104 weeks of age. Neo-
plastic histopathological findings in the liver which
showed sex-related trends included a hepatocellular ade-
noma in only one 104 week male. Non-neoplastic find-
ings included basophilic foci in females (3 and 12
animals at 78 and 104 weeks, respectively) but not in
males. Also, male predominant findings of bile duct
hyperplasia with increasing incidence with age were
observed. In summary, the incidences of neoplastic and
non-neoplastic lesions were typical of those observed in
historical control Fischer 344 rats of comparable age
[25].
Whole genome profiling of rat liver gene expression
was performed (n = 5) in each sex and age group using
Agilent microarrays. These rat whole genome microar-
rays contain 43,379 features or spots of which 23,233
have Entrez Gene IDs, 16,327 of which are unique.
Gene expression data were entered into ArrayTrack™
[26], the Food and Drug Administration’s database for
microarray data storage, processing, analysis and visuali-
zation that was created at the National Center for Toxi-
cological Research (NCTR). The composite liver gene
expression profiles for all genes (unfiltered) displayed
good reproducibility in general between animals of the
same sex and age group with average Pearson’s correla-
tions of R = 0.986 between biological replicates of the
same sex and age. Normalized intensity values were ana-
lyzed using a two-way ANOVA (sex, age) to calculate a
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Figure 1 Rat life cycle study design and animal body weight
growth curves. Untreated male and female F344 rats (A.) were
sacrificed at 2, 5, 6, 8, 15, 21 weeks (male and female n = 6 per age
group), 52 weeks (males n = 10, female n = 10), 78 weeks (male n
= 8, female n = 8) and 104 weeks (male n = 6, female n = 16) of
age corresponding to essential life stages (B.) during animal growth
and maturation. Liver tissues were collected and used for whole rat
genome expression profiling (n = 5 per sex, per age group). Animal
body weights (n = 6 to 16, +/-SEM) were recorded at necropsy.
Two week old animals were not weighed to decrease handling
stress. Rapid growth during early development subsides after
15 weeks and males reach nearly twice the weight of females at
52 weeks.
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Page 2 of 15p-value for statistical evaluation. Data for each spot
across all arrays were mean-scaled to calculate relative
fold-change differences in expression for each sex and
age. The initial filtering criteria of p < 0.05 for sex or
age difference with an absolute fold-change greater than
or equal to 1.5 in relative expression at any age was
used to define a set of 7,951 differentially expressed fea-
tures comprising 3,770 unique Entrez Gene IDs or dif-
ferentially expressed genes (DEGs). Using these 7,951
differentially expressed features, global expression pat-
tern analysis was performed using three-dimensional
principal component analyses (3D-PCA) within Array-
Track, wherein the three principal components captur-
ing the highest amount of variability in the DEG data
were plotted (Figure 2). These three principal compo-
nents captured approximately 58% of the total variability
present in the data (31.4%, 16.2% and 10.2% for PC1,
PC2 and PC3, respectively). Three-dimensional PCA
facilitates the visualization of individual animal expres-
sion data within each sex and age group and the global
relationships between one another. Male and female ani-
mals showed clear separation from each other for most
of the life cycle. Furthermore, most, if not all age groups
displayed temporal continuity with neighboring age
groups in a contiguous manner (i.e., expression profiles
from 6 week old animals of each sex lay in-between
t h o s eo f5w e e ka n d8w e e ka n i m a l si n3 D - s p a c e ,e t c . ) .
Lastly, the largest sex-differences in expression occurred
between 15 and 52 weeks of age, whereas the biggest
age-related differences occurred, as expected, between
the youngest animals (2 weeks) and adult animals (52
weeks).
A second clustering method, k-means clustering (JMP
Genomics 4.0, SAS. Cary, NC), was performed to show
individual gene profiles and to find groups of genes with
similar patterns of expression associated with specific
stages of development or aging (Figure 3). Male and
female data for each array feature were allowed to clus-
ter independently such that male and female data for a
given gene may group into separate clusters. The num-
ber of clusters was determined empirically according to
the fewest clusters required to achieve a minimum cor-
relation radius of 0.7 between any individual profile and
its cognate cluster members, resulting in 30 clusters.
K-means cluster analysis allowed for grouping of genes
based upon similarity of expression profiles across all
ages. The number of features included in each cluster
ranged from 16 to 2,252. Many clusters reflected tem-
poral patterns that could be readily interpreted in the
physiological context, such as high and low perinatal
expression (clusters 2 and 10, respectively) or up- (clus-
ters 6, 9, 14, 23) and down- (clusters 13, 18, 25, 26) reg-
ulation in the aging animals. Clusters also displayed
both sustained (clusters 2, 10, 11, 21) and transient
(clusters 3, 4, 15, 22, 24) patterns of regulation.
Although not all of the clusters are readily interpretable,
knowledge of rat growth patterns, sexual maturation,
and basic liver function assist in interpreting time-
course gene expression data. For example, cluster 2 and
cluster 10 (Figure 3) are negatively correlated with each
other yet both exhibit early and substantial changes
(between 2 weeks and 5 weeks) followed by negligible
change for the rest of the life cycle. Clusters 14 and 25
also negatively correlate with each other and show clear
and consistent upward and downward trends, respec-
tively, in the late age groups (between 52 weeks and 104
weeks). Thus, temporal patterns can be clearly distin-
guished for genes potentially involved in early develop-
ment vs. late aging based upon these life cycle clusters.
Sets of genes for which expression was at least 2-fold
greater in the opposite sex were determined for each
age group (p-value < 0.05; fold-change > 2 between
sexes) from the set of 3,770 DEGs described above. The
numbers of these sex-predominant genes at each age
are presented in Figure 4. The resulting plots indicate a
notable period from 6 to 21 weeks of age in which more
than 70% of the genes showing sex-predominance are
expressed at a higher level in females than males. From
the ages of 21 to 78 weeks, sex-predominant gene
expression was higher in males than females.
An unsupervised, pathway-analysis approach was per-
formed to identify functional categories of gene
response. Analysis software Ingenuity Pathway Analysis
(IPA) was used to assist in biological interpretation of
the expression data from the initial list of 3,770 DEGs
with unique EntrezGene IDs. Pathways which exhibited
large numbers of DEGs included metabolism of xeno-
biotics by cytochrome P450, fatty acid metabolism, tryp-
tophan metabolism, and acute phase response. Genes
involved with liver cholestasis, liver damage and liver
necrosis/cell death were highly represented in toxicity-
related functional analysis of the DEGs. Furthermore,
gene networks represented by the DEGs included seven
high-scoring IPA categories, including cell mediated
immune response, cell growth and proliferation, lipid
metabolism, organ morphogenesis, cell movement, and
hepatic system disease.
S i n c ed a t af r o ma l la g eg r o u p sw e r ei n c l u d e di nt h e
pathway analysis, the results are generic to the entire
life cycle and do not provide meaningful insight into
specific periods of the life cycle which may feature
unique expression patterns that would underlie age-
related susceptibilities. Thus, a more focused functional
analysis of targeted age groups was implemented. Adult
aging-related clusters (up-regulated with age: clusters 6,
14, 23; down-regulated with age: clusters 13, 18, 25, 26;
Figure 3) from the k-means cluster analysis were
selected and their corresponding gene lists were queried
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Page 3 of 15for pathways. Genes associated with organ injury/
abnormality (Crp (C-reactive protein), Il6st (interleukin
6 signal transducer), Stat3 (signal transducer and activa-
tor of transcription 3)) and lipid metabolism (Pon1
(paraoxonase 1), Apoa1 (apolipoprotein A1), Cyp27a1,
Abcg1 (ATP-binding cassette G1)), as well as toxicity-
related functions of liver cholestasis, necrosis and cell
death, were all up-regulated during the second year of
the rat life cycle. These gene family results overlap with
the top pathways represented in the up-late clusters
including acute phase response signaling, complement
system genes and xenobiotic metabolism. The clustering
of up-regulated gene families related to immune
response and cell death signaling pathways match well
with a presumed accumulation of aging hepatocytes
[27], the potential hepatic accumulation of fatty acids,
and increased demand for metabolic capacity for lipids
and xenobiotics which accumulate in the fat of aging
animals [28]. Genes that clustered in a pattern of down-
regulation in the adult aging rats are more difficult to
interpret as loss of expression may itself be a product
of the aging process [29]. However, a number of
2
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Figure 2 Three-dimensional principal component analysis. Global relationships between the expression patterns of individual animals were
visualized using the 7,951 differentially expressed features meeting the initial filtering criteria (p < 0.05 and at least +/- 1.5 relative fold change).
Each sphere represents the expression from one animal. Animals of the same sex and age have the same color and are labelled by age in weeks
(ArrayTrack). Females are indicated by black vertices or whiskers, males have none. Together, these data illustrate the relatively high
reproducibility between biological replicates (n = 5) in a discrete and continuous linear pattern from young to old animals. It also suggests clear
sex- and age-dependent differences in liver gene expression, with males and females exhibiting diverging profiles beginning at 2 weeks with
greatest differences observed at 21 and 52 weeks before converging again at 104 weeks.
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Figure 3 K-means cluster analysis of differentially expressed genes. Differentially expressed genes were clustered into 30 k-means clusters
(JMP Genomics, SAS 9.2) as this is the lowest number of clusters which allows a minimum correlation coefficient of R = 0.7 between any one
expression profile and its other cluster members. Male and female data were allowed to cluster independently between the 30 groups such that
male and female data might cluster to separate groups for a given gene. The x- and y-axes represent age and relative fold change, respectively.
Color is arbitrary and does not represent sex. These data illustrate the various biological patterns of liver expression which exist during pre-
pubertal, pubertal, early adult and aged rat life stages.
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Page 5 of 15represented gene networks in the aging-related down-
regulation clusters included cell signaling genes particu-
larly associated with the nervous system. A major hub
of many of the top represented gene networks in both
the up- and down-regulated, aging-associated clusters
was NF-B (nuclear factor B).
A supervised (pathway driven) approach was used to
specifically query three general gene ontology (GO)
areas of interest, namely xenobiotic metabolism, DNA
damage repair, and oxidative stress-related genes (Table
1). These gene categories are hypothesized to play
important roles in sex- and age-related susceptibility to
adverse drug effects [18,30]. Of the 122 genes included
in the xenobiotic metabolism gene list in the Ingenuity
Knowledge Base, 61 were differentially expressed. These
included Cyp2d4, the rat ortholog of human gene
CYP2D6, which is speculated to metabolize up to 25%
of commonly prescribed drugs [31]. Genes involved in
DNA Damage Repair, derived from Ingenuity, were
c o m b i n e dw i t ht h el i s tb yW o o de ta l .[ 3 2 ]t og i v e2 2 2
genes involved in DNA damage repair. Sixty-five of
these genes (approximately 25%) were found to be dif-
ferentially expressed in the liver. Oxidative Stress genes
were defined by 68 genes included in “response to oxi-
dative stress” (IPA) of which 23 genes were differentially
expressed (Table 1).
As a result of the global cluster analysis methods, var-
ious gene relationships in the expression data were
revealed from the analysis of correlated and anti-corre-
lated expression profiles (Figure 5A and 5B). Examples
of genes showing sex-divergent expression for both
male and female specific regulation were identified
(Figure 5C). Patterns of expression associated with spe-
cific developmental stages or periods of adult aging
were also evident and suggest age-specific regulation in
the liver (Figure 5D and 5E). Array based expression
profiles were verified using quantitative real time PCR
for four genes, using beta actin as a housekeeping con-
trol (Figure 6). Cyp2d4, the rat ortholog of human gene
CYP2D6, and Por (P450 oxidoreductase) are important
genes involved in Phase I xenobiotic metabolism. The
other two genes (Dbp and Arntl) are involved in circa-
dian rhythm regulation of gene expression in the liver.
An average correlation of R = 0.914 between qPCR and
array data was calculated for these four genes, demon-
strating high agreement between the two methods.
Expression profiles for specific examples of genes found
in xenobiotic metabolism pathways (Cyp2c11, Cyp2e1,
Cyp3a23/3a1, Gstm1, glutathione-s-transferase mu 1;
Slc22a8, solute carrier family 22 member 8) and energy
metabolism (Phgdh, 3-phosphoglycerate dehydrogenase),
which exhibit notable sex and age related differences,
are shown in Figure 7.
Discussion
The assessment of gene expression changes at key devel-
opmental periods of the life cycle, as well as at the ages
most commonly used in pre-clinical drug safety testing,
was the focus of this study. Fischer 344 rats are fre-
quently used in the National Toxicology Program and
one of the most commonly used inbred strains for pre-
clinical pharmaceutical in-life testing [25,33]. The two
early time points, 2 and 5 weeks, span the time of wean-
ing (3 weeks). The National Toxicology Program (NTP)
2-year bioassays are typically initiated in 6-8 week old
rats [34], thus 6 and 8 week age groups were included
to provide baseline for future NTP bioassays. The 15-
week age group captures expression data after sexual
and physical maturity [35]. Furthermore, a 13-week
NTP sub-chronic study, initiated in 8 week old animals
would be completed at 21 weeks. Reproductive senes-
cence and aging phenotypes begin to be apparent during
the second year [35], thus 52, 78, and 104 week age
groups were assessed.
Data analysis began with an unsupervised, or data-
driven, approach to interpreting the expression data.
Clustering methods were used to describe the global
relationships within the data on a per-group and per-
gene basis. Group relationships were illustrated in the
3D-PCA (Figure 2) which succinctly captures two major
trends in the expression data. Namely, the clear sex-
and age-related differences in expression shown by the
discrete spatial separation of groups visualized in these
parameters. Data from females follow a generally flat
linear trajectory while results from males show conspic-
uous divergence from females during adulthood
Figure 4 Temporal profile of sex-differences in liver gene
expression. The number of genes exhibiting a minimum 2-fold
difference in expression between male and female animals was
calculated at each age group. These data illustrate increased female
expression over males at 8 and 15 weeks which then is reversed
during early adulthood (21 to 52 weeks) where males show a
greater number of genes with higher gene expression than females.
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male convergence with female data is consistent with
previous reports of increasingly “feminized” liver expres-
sion patterns in older rats [18]. Such a large divergence
between males and females in the composite data sug-
gests a substantial proportion of the 3,770 individual
genes influencing this clear, sex-specific trend may be
related to sex steroid biosynthesis pathways. In fact,
upon analyzing the component or factor loadings for
the first three principal components (Figure 2), genes
from each principal component exhibited a unique char-
acteristic. Principal component 1 (PC1), when ranked by
factor loadings, consisted of genes exhibiting high
female expression and low male expression (female-spe-
cific top genes: Cyp2c12 (cytochrome P450, family 2,
subfamily c, polypeptide 12); Akr1b8 (aldo-keto
Table 1 Supervised analysis of differentially expressed genes from specified pathways
Cluster**
Category Pathway Entrez GeneID Gene Symbol P-value* (AGE) P-value* (SEX) P-value* (AGE^SEX) Female Male
DNA Damage Repair BER 304577 Ung 0.0026 0 0.2116 1 1
25332 Mgmt 0.778 0 0.0006 23 11
MMR 294252 Msh5 0.3511 0.0043 0.6288 9 23
NER 298074 Xpa 0.0002 0 0.7036 11 24
59102 Rpa2 0.5979 0.0042 0.0102 14 2
81513 Lig1 0.459 0 0.0009 6 2
Other 85472 Polg 0.0001 0.0022 0.1838 2 30
59294 Pold1 0.3243 0 0 14 2
316344 Rev1 0.0007 0 0.0009 15 2
84490 Fen1 0.0339 0 0.001 6 2
308755 Blm 0.0008 0 0.0021 7 2
309595 Mdc1 0.8699 0 0.0564 29 29
Xenobiotic Metabolism Phase 1 24300 Cyp2b1 0.1891 0 0.3345 12 10
378476 Cyp2c11 0 0 0 10 25
171521 Cyp2c13 0 0 0 29 10
266682 Cyp3a2 0 0 0 2 29
252931 Cyp3a18 0 0 0 21 25
170509 Cyp3a62 0 0 0 23 11
266674 Cyp4a8 0 0 0 1 25
Phase 2 24422 Gsta2 0.0189 0 0 1 8
24423 Gstm1 0 0 0 12 8
24424 Gstm2 0 0 0 1 8
24862 Ugt2b 0.3287 0.006 0.0082 9 25
Phase 3 25303 Abcc2 0 0 0.2455 8 8
140668 Abcc3 0 0 0 21 6
83500 Slc22a8 0 0 0 5 13
0 Slco1b3 0 0 0.0053 1 11
117048 Cdh17 0 0 0 4 25
25027 Slc16a1 0 0 0.0207 21 2
295356 Slc16a4 0 0 0 21 25
Oxidative Stress Response Nrf2 25315 Ephx1 0.0091 0 0.0458 1 1
Pathway 25256 Fmo1 0.1169 0.0008 0 6 10
113894 Sqstm1 0.1126 0 0.0394 1 1
24451 Hmox1 0.1788 0 0.182 14 14
29292 Ftl 0.5177 0 0.2465 12 12
24786 Sod1 0.0001 0 0.3873 8 1
24248 Cat 0.0035 0 0.0148 1 19
58819 Txnrd1 0.7899 0.0001 0.5142 12 10
291796 Usp14 0.0053 0 0.0001 21 29
*Two-way ANOVA results concerning AGE and SEX, n = 5, on normalized intensity values. “0” indicates p-values less than 1 × 10-6. **K-means cluster analysis of
expression profiles, agglomerative clustering, (Figure 3)
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Page 7 of 15reductase family 1 member b8); Sult2a1 (sulfotransferase
family 2a member 1); Prlr (prolactin receptor)). PC2-
ranked genes identified male-specific expression with
concurrent low female expression (male-specific top
genes: Mup5 (major urinary protein 5); Cyp2c13; Pgcl1/
Pgcl3/Pgcl5 (alpha-2u globulins 1, 3, and 5); Cyp2c11).
Whereas PC3-ranked genes included genes that exhib-
ited large-fold temporal differences, yet were positively
correlated between sexes (sex-conserved top genes:
Cyp17a1; A2m (alpha-2-macroglobulin); Col1a1 (col-
lagen, type I, alpha 1); Phgdh (3-phosphoglycerate dehy-
drogenase). The top 100 genes ranked by PC1 were
analyzed for gene ontology representation (ArrayTrack’s
Gene Ontology For Functional Analysis, GOFFA) with
“regulation of hormone levels”, “steroid metabolic pro-
cess”, and “hormone metabolic process” as the top three
GO terms which would support sex steroid hormone
biosynthesis pathways explaining the biggest sex differ-
ences in PC1.
Linear continuity between neighboring age groups
within each sex was maintained in the 3D-PCA, (e.g.,
6 week animal data spatially appear between 5 week and
8 week animals for both males and females). Addition-
ally, 3D-PCA permits the viewing of individual animal
data as they contribute to the average or composite
expression for one sex and age group. The relatively
tight clustering observed among animals (biological
replicates) of the same sex and age group illustrates the
degree of reproducibility in sex- and age-related expres-
sion profiles. In fact, correlation coefficients (R) varied
from 0.962 to 0.993 within a group when using DEGs,
demonstrating high biological similarity. Subsequently, a
k-means clustering method was used to bin individual
genes into groups according to their temporal profiles
(Figure 3). Such sorting algorithms establish the pre-
sence and prevalence of various patterns, thus
Figure 5 Comparisons of individual expression profiles. (A.)
Transcription factors Dbp and Tef are controlled by the circadian
clock-associated suprachiasmatic nucleus and exhibit conserved,
sex-specific life cycle profiles. (B.) Cux2 functions as a female-
specific repressor and putatively represses Cyp4a8 expression in
females but not males in an age-dependent manner. (C.) Cdh17
exhibits male-specific predominance in expression from 8 weeks
onward, while Stat3 shows female-specific predominance transiently
at 15 weeks. (D.) Both Por and Mgmt exhibit trends of increasing
expression during the second year of the rat life cycle and are
involved in xenobiotic metabolism and DNA damage repair,
respectively. (E.) Early developmental transition between Igf2-
predominance at 2 weeks to Igf1-predominance by 6 and 8 weeks
in the liver is shown at the expression level. The right Y-axes
present in panels C and E represent data for Stat3 and Igf1,
respectively, to show differences in scale.
Figure 6 Quantitative real time PCR verification of selected
genes. Microarray expression profiles for Cyp2d4, Por, Dbp and
Arntl were assessed by qRTPCR using gene specific Taqman probes.
Housekeeping gene beta-actin was used to standardize expression.
In each case, the qRTPCR data very closely approximated the
microarray expression levels and are temporally correlated in both
sexes. Pearson’s correlations were calculated between averaged
microarray (uA) and qRTPCR (RT) data for each gene and
coefficients ranged from R = 0.810 to 0.985. Blue and red lines
indicate male and female qRTPCR data, respectively (n = 5), and
black lines represent microarray data (n = 5, error bars represent
SEM for qRTPCR).
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that can be assessed in the context of biological neces-
sity or functionality in the liver. These clustered tem-
poral profiles gain more interpretive potential when
correlated with gross biological trends (such as the
growth curves of animal body or liver weight) or devel-
opmental windows (sexual and physical maturation).
The k-means clusters can then be associated with var-
ious developmental stages such as acute growth, pub-
erty, early adulthood, and adult aging. For example, the
transition from perinatal to pubertal control of growth
and differentiation is believed to be directed in part by
the switch from, Igf2 (insulin-like growth factor 2)
expression to predominantly Igf-1 expression in the liver
[36] during early development. These gene expression
changes are illustrated in the different patterns shown in
cluster 2 (Figure 3) for Igf-2 versus clusters 8 and 12 for
Igf-1. Igf-2 exhibits high expression at 2 weeks (100- to
500-fold change above average for female and male,
respectively) followed by relatively low and constant
expression at the remaining age groups. Igf-1, however,
shows low expression at 2 weeks followed by peak
expression between 8 and 21 weeks in both sexes (Fig-
ure 5E). Another example, Phgdh, ranked high in the
principal component 3 (PC3) factor loadings which
exhibited sex-conserved, age-specific expression profiles.
In this case, Phgdh fell into clusters 22 and 29 (male
and female, respectively), demonstrating transient up-
regulation between 5 and 6 weeks with declining expres-
sion in subsequent age groups. This expression pattern
is consistent with the known association of Phgdh with
highly replicating cells as the first and rate-limiting step
in de novo biosynthesis of serine [37], which also plays a
role as nucleotide precursor in regenerating liver tissue
and hepatomas [38]. Thus Phgdh’s transient up-regula-
tion during early liver growth phase (5-6 weeks) is con-
sistent with this physiological role. These patterns
illustrate the temporal relationships between their
expression and roles in liver development.
Several k-means clusters exhibit patterns of up-regula-
tion with age. Clusters 6, 14 and 23 (Figure 3) in particu-
lar show an upward trend between 52 and 104 weeks,
suggesting a group of genes important in the adult aging
process. Examination of these genes using Ingenuity
Pathway Analysis suggests many may be involved in com-
pensatory mechanisms adapting to higher levels of liver
injury, DNA damage or loss of function. For example,
Mgmt (O6-methylguanine DNA methyltransferase) is a
DNA damage repair enzyme which acts to directly
reverse alkylation adducts in DNA [39]. Mgmt was found
in clusters (clusters 11 and 23, male and female, respec-
tively) which exhibit a trend toward of increasing expres-
sion in late adulthood (between 21 weeks and 104 weeks)
(Figure 5D) which is consistent with previous reports
associating Mgmt with aging phenotype [40]. Likewise,
Por (P450 oxidoreductase) is a member of the “up-late”
clusters. Por’s microarray expression patterns were
further verified by Taqman quantitative real time PCR
(qRTPCR) (Figure 6). Interestingly, Por, along with cyto-
chrome b5 [41], is a key electron donor for microsomal
cytochrome P450 monooxygenases (CYP enzymes) [42],
many of which function as Phase 1 metabolizing enzymes
during xenobiotic metabolism. Por essentially acts to
reload CYP enzymes in their monooxygenase activities.
Por’s reductase activities also target a number of other
oxygenase enzymes involved in sterol and cholesterol bio-
synthesis, heme degradation to bilirubin, and fatty acid
metabolism [42]. Thus, Por’s consistent up-regulation
from 52 weeks to 104 weeks could be explained by
increased demand for CYP enzyme reloading due to
accumulated xenobiotic exposure or fatty acid accumula-
tion as a function of the adult aging process.
Other genes associated with “up-late” clusters
(k-means clusters 1, 6, 9, 14, 23) included several
Figure 7 Individual examples of expression profiles. Microarray
data fold-changes for selected genes are plotted (n = 5, error bars
represent SEM). Solid and dashed lines indicate male and female
expression, respectively. Averaged expression levels (normalized
fluorescence intensities) across both sexes and all time points are
reported for each gene and have been scaled to equal “1” in the
graph.
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Page 9 of 15oxidative stress related genes including Ephx1 (epoxide
hydrolase 1), Fmo1, Fmo5 (flavin containing monooxy-
genase 1 and 5) and Hmox1 (heme oxygenase 1).
Hmox1 is an important antioxidant protein expressed in
response to oxidative stress [43], and thus its continuous
increase in expression in older animals suggests a com-
pensatory mechanism specifically to address increased
levels of reactive oxygen species in the liver.
Expression level is not always an indicator of protein
activity. For example, a previous report showed changes
in male rat hepatic Cyp2e1 activity between 3 and 18
months of age despite the relative stasis of mRNA and
protein levels [44]. However, examination of Cyp2e1
gene expression on a finer scale, as was done in this
study, revealed sex-conserved spikes in young animals
(between 2 weeks and 8 weeks) followed by greater than
2-fold differences in expression level between sexes at
21 weeks (Figure 7). Therefore, care must be taken in
interpreting changes in mRNA expression levels on
their own. This broader examination using more time
points during the life cycle may prevent over-interpreta-
tion of expression data captured in studies of smaller
scope.
Male rodents are preferred in many studies evaluating
toxicological or pharmacologic response in vivo due to
adult female variability in response during estrous cycle
[45]. However, the current study using unsynchronized
females is a crucial starting point to evaluating sex dif-
ferences in liver expression over the larger scale of the
life cycle. The number of replicates per age group (5 per
age group) and relative consistency across multiple adult
age groups increases our confidence in the sex-specific
differences. Whereas Mori et al. [17] were limited to
comparisons of relatively young (32 weeks) and old
males (84 weeks), a full life-cycle analysis in both sexes
provides comprehensive data on the temporal dynamics
of gene expression and evaluates how well correlated
m a l ea n df e m a l ed a t aa r et h r o u g h o u tt h el i f ec y c l e .I f
and when male and female data do not comport with
each other, these sex-differences may inform our assess-
ments of clinical (human) response which may influence
the sex and age of rodent models used for pre-clinical
testing. Wauthier et al [22] provide comprehensive lists
of male- and female-specific liver gene expression in
approximately 13 week old rats. A comparison of their
top 100 male- and female-specific genes with the top
100 male/female-specific genes from the 15 week age
group of the current data set was performed. An overlap
of 73% (46/63, matched by Agilent probe ID) and 61%
(43/71) for male- and female-specific expressed genes,
respectively, were identified, suggesting a good degree of
overlap of the most sex-specific genes. Furthermore, Lee
et al. [14] complemented their male data with a meta-
analysis of sex-specific genes from a separate study [46]
and showed age-related changes in xenobiotic metabo-
lism genes in the course of 6, 11, 18 and 24 month old
rats. However, because the male and female data were
not from the same study and the time and sex analyses
were evaluated separately, inter-study confounding fac-
tors can not be adequately controlled for. Thus, analysis
of sex- and age-related changes between animals within
the same in-life study, as reported here, removes any
uncertainties with regard to such confounding factors
and allows for more robust comparisons.
Efforts have been made using differing metrics (com-
paring times of weaning, sexual maturity, skeletal matur-
ity, etc.) to align the life cycle of normal human
development and maturation with that of the rat [35],
illustrating the compressed timescale that exists in
rodent models. Properly extrapolating information about
specific windows of development or aging from rodents
to humans is therefore only approximate; however, the
comprehensive gene expression profiles throughout the
life cycle of the rat reported here may help further
refine the life-cycle alignment of the rat model to
human.
The FDA has assembled a listing of valid genomic
biomarkers in the context of approved drug labels that
are used in a variety of specific uses, including evaluat-
ing clinical response and differentiation; risk identifica-
tion; dose selection guidance; susceptibility, resistance
and differential disease diagnosis; and polymorphic
drug targets [47]. Of the 20 gene-specific biomarkers
on the FDA list, 13 of the genes were present on the
Agilent arrays and 8 of them were differentially
expressed by age or sex. Of these 8 genes, CYP2C9
(rCyp2c11), CYP2D6 (rCyp2d4), and EGFR (epidermal
growth factor receptor), exhibited notable sex-differ-
ences in gene expression patterns in this study.
Cyp2c11 showed much greater (200-250 fold differ-
ence) male-specific expression from 8 to 52 weeks of
age. Both Cyp2d4 and Egfr showed ~1.5 and 2-fold
higher expression, respectively, in males from 15 to 52
weeks. The relative expression of cytochrome P450
enzymes may have sex- and age-specific implications
for the liver; however, Egfr was validated as a biomar-
ker for cancer in non-hepatic tissues. Two other of the
9 DEGs, Dpyd (dihydropyrimidine dehydrogenase) and
Nat1 (N-acetyltransferase 1), exhibited sex-conserved
repression (~-2-fold) at early ages (2 and 5 weeks) fol-
lowed by minimal changes at later ages. The remainder
of the validated biomarkers that were differentially
expressed during the rat life cycle showed few or mini-
mal changes in expression that were very close to the
screening criteria threshold. Thus, the expression levels
of these biomarkers vary through the life-cycle of the
rat model and this may have implications for their
appropriate use.
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expression of xenobiotic metabolism genes during the
24-hr cycle [48]. There are also reports that changes in
circadian control during the aging process may, in addi-
tion, impact xenobiotic metabolism capacity during the
life cycle [49]. Master circadian regulators Clock and
Arntl/Bmal1 (aryl hydrocarbon receptor nuclear translo-
cator-like) control the expression of the PARbZip family
of transcription factors which is comprised of three
members: Dbp (albumin site D-binding protein), Tef
(thyrotroph embryonic factor), and Hlf (hepatocyte leu-
kemia factor). In turn, these PARbZip transcription fac-
tors have been shown to regulate several enzymes and
regulators involved in detoxification and drug metabo-
lism, such as cytochrome P450 enzymes, carboxyles-
terases and constitutive androstane receptor [50]. The
genes for two of these transcription factors, Dbp and
Tef, were found to be differentially expressed through-
out the life cycle in an age- and sex-specific manner
(Figure 5A) and also to be highly correlated between the
sexes (Pearson, R = 0.94). Furthermore, humans exhibit
sexually dimorphic patterns of suprachiasmatic nucleus
(SCN) neuron deterioration, with women showing no
change throughout adulthood while men exhibit com-
plex and fluctuating patterns with increasing age [51]. It
is interesting to note that the pattern of SCN-controlled
clock genes, Dbp, Tef, and Hlf (Hlf’s 1.3-fold change did
not meet criteria for inclusion in list of DEGs) display a
conspicuous correlation with these reports (Figure 5A).
Namely, while female expression remains consistent
between 52 weeks and 104 weeks, males exhibit com-
parable levels of expression to female at 52 and 104
weeks but a noticeable decrease at 78 weeks. The micro-
array expression profiles of Dbp and Arntl/Bmal1 were
further verified by qRTPCR (Figure 6). Based upon the
known common pathway (Dbp and Tef controlled by
the SCN) and life cycle expression data exhibiting corre-
lated and sex-specific patterns, these data suggest a
shared regulatory mechanism between the PARzip
family members’ expression and the sex-specific pattern
of SCN neuronal deterioration. This further supports
the concept that the circadian clock may influence life
cycle “clocks” and thus influence downstream xenobiotic
metabolism capacity.
The major mechanisms controlling sex differences in
liver gene expression have been well-characterized [52]
and are dictated by the distinct patterns of continuous
vs. pulsatile plasma growth hormone (GH) secretion in
females and males, respectively [53]. These temporal dif-
ferences in plasma GH levels influence the activity of
transcription factors Stat5b (signal transducer and acti-
vator of transcription 5b), Hnf4a (hepatic nuclear factor
4, alpha), and Stat5a (signal transducer and activator of
transcription 5a), which then differentially activate
sex-specific cytochrome P450s (CYPs) such as Cyp2c
family members. Several Cyp2c family members ana-
lyzed in this study exhibited clear and conspicuous dif-
ferences in expression, including Cyp2c7, Cyp2c11,
Cyp2c13, Cyp2c12, Cyp2c79, and Cyp2c22. Previous stu-
dies of rat liver gene expression have also shown age-
related changes in xenobiotic metabolism genes,
although only male rats were examined, [17] and
included Cyp2c11 and Cyp3a2. Both of these genes were
represented on the Agilent array used in this study and
showed comparable changes in gene expression at simi-
lar age groups along with related family members
(Cyp2c13 and Cyp3a23/3a1, Cyp3a9 and Cyp3a18). A
number of xenobiotic metabolism related receptors of
interest were present on the array but were either not
differentially expressed (pregnane X receptor, Nr1i2;
constitutive androstane receptor, Nr1i3; aryl hydrocar-
bon receptor, Ahr; peroxisome proliferator-activated
receptor alpha and gamma, Ppara/Pparg; retinoid x
receptor alpha and beta, Rxra/Rxrb) or minimally passed
threshold criteria for differential expression (retinoid X
receptor, Rxrg). Cyp1a2, a notable xenobiotic and drug
metabolizer and known target of Ahr, exhibited roughly
parallel expression between sexes with maximum rela-
tive expression (~1.5 fold) peaking around 6 to 8 weeks
followed by declining expression with age. Of the 34
phase I and II metabolizing genes found to be changed
with age in male animals by Mori et al. [17], 27 were
present in this study’s list of DEGs and showed compar-
able expression changes across corresponding time
scales. However, it is important to note that the female
patterns differed remarkably from males in over 50% of
those genes, raising uncertainties regarding how well
data from male animals reflect the female response.
Data for Cyp2c11 and Cyp3a23/3a1 are shown in Figure
7.
It has also been shown that GH regulates Cux2 (cut-
like homeobox 2) which has been suggested [54] to act
as a suppressor of male-specific gene expression. Laz
et al. [54] employed in silico methods to predict binding
sites of Cux2 suggesting target proximal genes for
repression. In the current data set, when life cycle pro-
files for Cux2 were compared to the 16 suggested target
genes, a clear sex-specific repressive relationship was
observed with one of the genes, Cyp4a8 (R = -0.699 in
males; Figure 5B). Cux2 showed approximately 12-fold
expression ratio difference between males and females
from puberty through early adulthood, while Cyp4a8
showed approximately 11-fold sex difference (male/
female) in expression level. These comparative life cycle
expression data provide further evidence of Cux2’sr o l e
in sex-specific repression of Cyp4a8. Cyp4a8 is also a
target of PPARa (peroxisome proliferator activated
receptor alpha) signaling [55] and its expression has
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the susceptibility to hypertension and target organ
damage [56]. Thus these data suggest integrated sex-
specific control of genes like Cyp4a8 that are also
involved in xenobiotic receptor mediated responses.
To discover further large-scale patterns of sex-specific
life cycle gene expression, the data were analyzed on a
per-age group basis assessing the number of instances
where the expression difference of a given gene between
the sexes was at least 2-fold, with the condition that the
data at that individual age group first met the screening
criteria of p < 0.05 and great than or equal to 1.5 rela-
tive fold-change (Figure 4). The periods of the life cycle
in which one sex predominates over the other in expres-
sion level appear to be non-random and appear at dis-
crete times of the life cycle. For example, female
predominant expression prevails during or soon after
sexual maturation and into early adulthood (8 and 15
weeks) whereas male predominant expression appears to
peak between 21 and 78 weeks of age. Interpreting this
result in light of the 3D-PCA analysis, the data suggest
that differences between males and females are observed
immediately at 2 weeks, with more noticeable sex-diver-
gence at approximately 6 weeks (Figure 2) which
extended through sexual maturation. This sex-diver-
gence seems to be due at first to genes being expressed
at higher levels in females than males (Figure 4), fol-
lowed by a transition where male expression is higher
than females throughout the majority of adulthood. For
example, Stat3 exhibits transient, female-specific predo-
minance at 15 weeks while Cdh17 (cadherin 17) shows
clear male-specific expression between 8 and 104 weeks
(Figure 5C). Only one clear example, Cyp3a23/3a1 (Fig-
ure 7), was found among the 122 xenobiotic metabolism
genes that exhibited both the female predominant
expression at 15 weeks and male predominant expres-
sion at 52 weeks, suggesting that the sex-specific predo-
minance of expression observed in Figure 4 primarily
occurs in different sets of genes. The large-scale patterns
observed in the global analyses (Figures 2 and 4) are
also observed in individual gene profiles (Figure 7),
including several cytochrome P450 family members in
addition to other xenobiotic metabolizing proteins
(Table 1).
Conclusions
This study comprises one of the most comprehensive
data sets to date for rodent liver gene expression with
regards to sex, life span, biological replication, and gen-
ome coverage. A broad description of the dataset in the
context of the normal physiology of the rat life cycle
suggests important implications for toxicological sus-
ceptibility as related to xenobiotic metabolism, DNA
damage repair and oxidative stress response. Namely,
principal component analysis identified and ranked
genes which exhibited the greatest sex-specific and sex-
conserved differential expression. Furthermore, specific
periods of the life cycle were identified that display a
higher number of genes with sex-specific expression
which included putative toxicological susceptibility
related genes (e.g., Cyp2d4, Cyp3a23/3a1, Gstm1,
Slc22a8). Cluster analyses, in combination with func-
tional annotation analysis, identified gene clusters that
positively correlated with adult aging which also
included several susceptibility related genes (i.e., Por,
Mgmt). Lastly, life cycle expression data provided
experimental support for gene regulatory relationships
previously based upon in silico predictions alone (i.e.,
Cux2, Cyp4a8).
The ability to make informed regulatory decisions
about the impact of drugs and other chemicals on the
liver is dependent upon a growing understanding of
liver biology and more specifically the expression pro-
files of the molecular components which play a role in
the pharmacokinetics and pharmacodynamics in liver
cells. This large-scale study captures comprehensive
baseline hepatic gene expression profiles during the life
cycle of male and female rats which should prove to be
an increasingly valuable resource for toxicogenomics-
related research and ongoing evaluations of pre-clinical
and clinical biomarkers of toxicity and efficacy.
Methods
Animal Study
Male and female (unsynchronized) Fisher 344 rats
obtained from NCTR’sa n i m a lb r e e d i n gc o l o n yw e r ef e d
the NIH-31 diet (ad libitum)a n dh o u s e du n d e rA A A -
LAC-approved conditions with a 12-hr light/dark cycle
(0600 - 1800). Rats were housed two per cage in stan-
dard polycarbonate cages with hardwood chip bedding
maintained at 23 degrees C with a relative humidity of
~50%. Animals were sacrificed at 2, 5, 6, 8, 15, 21 weeks
(male and female n = 6 per age group), 52 weeks (males
n = 10, female n = 10), 78 weeks (male n = 8, female
n = 8) and 104 weeks (male n = 6, female n = 16) of
age. Additional animals were included in the 52, 78, and
104 week time points to compensate for anticipated loss
of animals during the course of the experiment. These
numbers were based upon natural survival curves of
these animals. Rats were treated according to the NCTR
Institutional Animal Care and Use Committee
guidelines.
Necropsy
Animals were sacrificed at the same circadian time
(between 0900 and 1100) for each time point and eutha-
nized by carbon dioxide asphyxiation. Body weights
were recorded and right lateral lobe sections of liver to
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RNAlater (Ambion, Foster City, CA) for 24 hr at room
temperature followed by storage at -20 degrees C. Sec-
tions were collected at 52, 78 and 104 weeks for histolo-
gical examination and placed in 10% neutral buffered
formalin. Additional tissues including kidney, brain, pan-
creas, heart, lungs, muscle, uterus and testes were also
collected in a similar manner.
RNA Isolation
Total RNA was isolated from approximately 30 mg liver
sections using Qiagen RNeasy Mini Kit (Qiagen Inc.,
Valencia, CA) according to manufacturer’sp r o t o c o l .
The yield of the extracted RNA was determined spectro-
photometrically by measuring the optical density at
260 nm (Nanodrop-1000, Thermo Scientific, Wilming-
ton, DE). The purity and quality of extracted RNA were
evaluated using the RNA 6000 LabChip and Agilent
2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).
RNA samples with RNA integrity numbers (RINs)
greater than 8.0 were used for microarray and real time
PCR experiments with an average of 8.7 for all samples.
Microarray Experiments
Gene expression studies (n = 5 per group) were com-
pleted using single color (Cy3) Agilent Whole Rat Gen-
ome 4 × 44k microarrays, which contain 4 identical
arrays per slide, and reagents according to manufac-
turer’s protocols (Agilent Technologies, Santa Clara,
CA) for cRNA labeling and hybridization using 500
nanograms of total RNA. An Agilent one-color spike-in
kit was used as a positive control and to monitor label-
ing efficiency across all experiments. A universal rat
reference (URR) RNA (Stratagene, Agilent Technologies)
was labeled and incorporated into the array design to
control for batch/day effects during data processing. In
total, six URR hybridized arrays were included in the
study. Pair-wise Pearson’s correlations between un-nor-
malized individual URR array intensity values (F532-
median) ranged from R = 0.968 to 0.997. Samples were
randomized by sex and age such that biological repli-
cates of the same group were not hybridized to the
same slide. Arrays were scanned for fluorescent signal
intensities using a GenePix 4000B microarray scanner
(Molecular Devices, Union City, CA). Images were ana-
lyzed for feature and background intensities using Gene-
Pix Pro 6.0 software (Molecular Devices). Full
microarray data are available at Gene Expression Omni-
bus with accession GSE21335 [57].
Microarray Data Analysis
Microarray intensity data were uploaded to the Array-
Track database [26] and normalized using 75
th-percen-
tile scaling without background subtraction. Statistical
analyses were performed on normalized intensity values
using a two-way ANOVA (sex and time-point) in Array-
Track. Relative fold-change values were calculated for
data from each sex and time point. These relative fold-
changes (individual values divided by the averaged
expression from both males and females) were calcu-
lated on a per spot/feature basis. The MicroArray Qual-
ity Control (MAQC) Consortium [58] suggests the use
of a fold-change cut off along with a non-stringent
p-value cut off as a baseline practice to improve repro-
ducibility in microarray data processing. Therefore,
filtering criteria, consisting of a p-value < 0.05 and an
absolute fold-change value of 1.5 or greater at any time
point, were used to define an initial set of differentially
expressed genes. Applying these criteria to the 41,897
features on the Agilent microarrays resulted in 7,951
array features (consisting of 3,770 unique Entrez Gene
IDs) being designated as differentially expressed. The
complete data set with annotations, fold-changes and
p-values, k-means clusters, and 3D-PCA loadings data is
available in Additional File 1, Table S1. For brevity and
consistency, genes are referenced by their official gene
symbol as defined by NCBI. Three-dimensional principal
component analysis (3D-PCA) was performed on nor-
malized intensity values of the 7,951 differentially
expressed features in ArrayTrack. K-means cluster ana-
lysis was also performed on the 7,951 differentially
expressed features using JMP Genomics (SAS 9.2). The
number of initial clusters chosen was 30 as this was the
lowest number of clusters to allow a minimal correlation
coefficient of R = 0.7 for any feature profile in its
respective cluster. Functional annotation and pathway
analysis of gene expression data was performed using
Ingenuity Pathway Analysis (Ingenuity Systems, Red-
wood City, CA). Default settings for expression dataset
analysis were used and results from Top Networks, Bio-
and Tox- Functions and Canonical Pathways were quer-
ied to facilitate the biological interpretation of gene lists.
Quantitative Real Time PCR Analysis
For each sample, 0.5 μg of total RNA was reverse tran-
scribed by MultiScribe reverse transcriptase using ran-
dom primers as described by the manufacturer (Applied
Biosystems, High-Capacity Reverse Transcription Kit).
The resultant cDNA (1.0 μl )w a su s e da st h et e m p l a t e
in a 20 μlT a q m a nE x p r e s s i o nA s s a yP C Rr e a c t i o n
(Applied Biosystems, Foster City, CA) for Cyp2d4
(Assay ID: Rn01504629_m1), Por (Rn00580820_m1),
Arnl (Rn00577590_m1), Dbp (Rn00497539_m1) and
Actb (Rn00667869_m1). Taqman PCR was conducted in
MicroAmp Optical 96-well reaction plates (Applied Bio-
systems) on an ABI 7500 real-time PCR detection sys-
tem. The gene expression level of each sample for each
gene was standardized to the house-keeping gene, Actb,
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Page 13 of 15to control for differences in RNA loading, quality and
cDNA synthesis using the ΔΔCt method. For graphing
purposes, the relative expression levels were scaled such
that the expression level of the mean expression for
males and females was equal to one.
Additional material
Additional file 1: Supplementary Data Table S1. A listing of all
differentially expressed genes, annotations, relative fold change values, p-
values, k-means clusters and principal component analysis loadings
values. Open with MS Excel or comparable spreadsheet software.
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